PAVmed, a New York-based medical device company, specializes in medical technologies and employs 107 staff. Its subsidiaries include Lucid Diagnostics, offering cancer detection products, and Veris Health, focused on personalized cancer care.
PAVmed (PAVM) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, PAVmed's actual EPS was -$0.74, missing the estimate of -$0.13 per share, resulting in a -458.07% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
